MoneyWorks4Me

Cipla informs about press release

07 Jul 2023 Evaluate

Cipla has informed that it enclosed press release dated 7th July 2023 titled ‘Voluntary nationwide recall of six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to container defect by Cipla USA Inc., wholly owned step down subsidiary of the Company in USA’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..